San Francisco startup Construction Therapeutics is usually working on an oral, as soon as-everyday GLP-1 drug called GSBR-1290—the drug surpassed Wall Street’s expectations in June every time a mid-stage review confirmed average weight loss of close to 6% and it programs to start One